Paras Tak

Dr. Paras Tak

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2019 in Journal of Nanoscience and Technology
Verified
Journal Article
Open access
TJTessy John
Tessy John
KPKokila A. Parmar
Kokila A. Parmar
PTParas Tak
Paras Tak

14 November 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
PTParas Tak
Paras Tak
VSVishnu Suturiya
Vishnu Suturiya
MMMayank R. Mehta
Mayank R. Mehta
GVGrilesh Vyas
Grilesh Vyas
Herbs and Plants have been the most important form of medicine in India since ancient times. the plant kingdom is a goldmine of potential drugs and active molecules. Medicinal plants played a vital role in manufacturing human health and improving the quality of human life for thousands of years. During the last decade, the use of traditional medicine has expanded globally and gained popularity. Medicinal plants have healing properties due to the presence of various complex chemical substances of different compositions. Medicinal plants have served humans well as valuable components of medicines, flavorings, beverages, cosmetics, and dyes. Ficus religiosa is one of the medically important plants belonging to the family of Moraceae. It has been used broadly by Ayurvedic practitioners in India to treat various diseases. The present work is an endeavor to improve the effectiveness of synthetic drugs in combination with plant extracts.

28 December 2021 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
KGKetan Gadani
Ketan Gadani
PTParas Tak
Paras Tak
MMMayank Mehta
Mayank Mehta
NSNeetu Shorgar
Neetu Shorgar

7 September 2026 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
NPNageswararao Pulakundam
Nageswararao Pulakundam
BPBhavesh D. Patel
Bhavesh D. Patel
NPNaresh P.
Naresh P.
MJMonika Jangid
Monika Jangid
PTParas Tak
Paras Tak
Objective: This study aimed to develop and validate a sensitive LC–MS/MS method for quantifying a novel Secretory phospholipase A₂ (sPLA₂) inhibitor, compound-7(L), in mouse plasma and to evaluate its application in pharmacokinetic studies. Methods: A bioanalytical LC–MS/MS method was developed and validated according to ICH M10 guidelines. Compound-7(L) was extracted from mouse plasma using protein precipitation. Pharmacokinetic studies were conducted in male C57BL/6 mice following intravenous administration at a dose of 1 mg/kg. Results: The method was linear over the range of 0.100–100 ng/ml with regression coefficient>0.99. Intra-and Inter-run accuracy ranged from 89.67% to 105.00% and 90.00 % to100%, respectively. The intra-and inter-day precision values were1.88% to 9.52% and 0.30 % to 4.00%, respectively. All stability assessments were within acceptance criteria of ±15%. Conclusion: The method exhibits excellent specificity and selectivity, with well-fitted linearity over the validated concentration range. The established method, validated in line with ICH M10 guidelines, was shown to be accurate, precise, rugged, and stable in mouse plasma, meeting all specified acceptance criteria. Overall, the validated method, owing to its simplicity, sensitivity, and cost‑effectiveness, is suitable for mouse plasma analysis and supports its application in pharmacokinetic study.